Patents Represented by Attorney, Agent or Law Firm Barbara Rae-Venter
  • Patent number: 5792467
    Abstract: Repellent compositions which contain aromatic aldehydes such as cinnamic aldehyde, .alpha.-hexyl cinnamic aldehyde and/or coniferyl aldehyde are provided, together with methods for their use as repellents for pests including flies, cockroaches, aphids, silverleaf white flies, mosquitoes, ticks, fleas, lice, leafhoppers, thrips, two-spotted spider mites, snails, slugs, biting midges, earwigs, and moths. Also provided are stabilized .alpha.-hexylcinnamic aldehyde (HCA) compositions which reduce the evaporation rate of HCA and/or induce HCA to evaporate at a constant rate over time.
    Type: Grant
    Filed: December 24, 1996
    Date of Patent: August 11, 1998
    Assignee: Proguard, Inc.
    Inventors: Ralph W. Emerson, Bradford G. Crandall, Jr.
  • Patent number: 5738861
    Abstract: The present invention provides methods and compositions for inhibiting microbial growth through the use of flavonoid aldehydes or alcohols for the purpose of disinfecting contaminated environments. The methods include the step of contacting the unsterile area with an amount of a flavonoid aldehyde or alcohol sufficient to control growth of pathogenic microbes. The aldehyde or alcohol can be provided in a variety of formulations.
    Type: Grant
    Filed: November 22, 1995
    Date of Patent: April 14, 1998
    Assignee: Proguard, Inc.
    Inventors: Ralph W. Emerson, Bradford G. Crandall, Jr.
  • Patent number: 5643791
    Abstract: A biologically pure DNA sequence which encodes an endo 1,4-.beta.-glucanase, useful for the efficient conversion of cellulose to glucose, is disclosed. Also disclosed are recombinant DNA cloning vehicles (vectors) that contain nucleotide sequences that encode for the aforesaid endoglucanase, proteins that exhibit endoglucanase activity, expression-controlling DNA sequences, microorganisms that contain recombinant DNA cloning vehicles, as well as messenger RNA sequences complementary to a DNA strand of the aforesaid DNA nucleotide sequences.
    Type: Grant
    Filed: January 19, 1994
    Date of Patent: July 1, 1997
    Assignee: University of British Columbia
    Inventors: R. Anthony J. Warren, Douglas G. Kilburn, Robert C. Miller, Jr.
  • Patent number: 5629149
    Abstract: The present invention provides a process for determining genotypes in highly polymorphic systems by polymerase chain reaction amplification of cDNA or genomic DNA and direct sequencing polymerase chain reaction products using oligonucleotide primers. More specifically, Class II and Class I HLA genotypes can be unambiguously determined in any subject in 16-24 hours by direct sequencing of DRB, DQB, DQA, DPB, DPA, HLA-A, HLA-B and HLA-C- transcripts enzymatically amplified using a limited number of non-allele-specific oligonucleotides. Total cellular RNA from peripheral blood mononuclear cells is reverse transcribed using antisense primers, specific for different locus (DQB, DQA, DPA or DPB) or group of loci (DRB1-5, or HLA-A and HLA-B and HLA-C). The synthesized cDNA molecules are then enzymatically amplified using different combinations of oligonucleotides for each locus and directly sequenced with Taq polymerase using an internal oligonucleotide. The sequenced genes are then analyzed.
    Type: Grant
    Filed: August 16, 1993
    Date of Patent: May 13, 1997
    Assignee: Regents of the University of Minnesota
    Inventors: Pedro Santamaria, Michael T. Boyce-Jacino, Jose J. Barbosa, Stephen S. Rich, Anthony J. Faras
  • Patent number: 5538878
    Abstract: Plant species having enhanced superoxide dismutase activity as a result of transformation with a DNA expression cassette comprising an E. coli MnSOD gene are provided. Transportation of the expression product of the gene may be targeted to a specific cell organelle, such as the chloroplast.
    Type: Grant
    Filed: July 19, 1989
    Date of Patent: July 23, 1996
    Assignees: Calgene, Inc., Procida
    Inventors: Bruce Thomas, H. Maelor Davies, Jean Kridl, Jeffery K. O'Neal, C. Jacques Van Assche
  • Patent number: 5530185
    Abstract: Novel DNA constructs are provided which may be used as molecular probes or inserted into a plant host to provide for modification of transcription of a DNA sequence of interest in ovary tissue, particularly in very early fruit development. The DNA constructs comprise a transcriptional initiation regulatory region associated with gene expression in ovary tissue from immediately prior to anthesis through flower senescence.
    Type: Grant
    Filed: December 29, 1992
    Date of Patent: June 25, 1996
    Assignee: Calgene, Inc.
    Inventors: Belinda M. Martineau, David M. Stalker, Ann A. Reilley
  • Patent number: 5529917
    Abstract: Novel microbial host strains are provided which are transformed by a vector molecule comprising a DNA fragment encoding a lipolytic enzyme and a marker for selection, capable of producing active lipase. Said DNA fragment is preferably derived from a Pseudomonas species.
    Type: Grant
    Filed: January 11, 1994
    Date of Patent: June 25, 1996
    Assignee: Gist-brocades
    Inventors: Peter M. Andreoli, Maria M. J. Cox, Farrokh Farin, Suzanne Wohlfarth-Rippel
  • Patent number: 5513661
    Abstract: Methods are provided for intramuscular needle diagnosis and treatment of muscle pain that is believed to be the result of sympathetically mediated spindle spasm. Two simultaneous needle EMG needle recordings are used to establish the presence of and magnitude of the "trigger points" in painful muscle. The abnormal muscle activity so identified can then be treated by blocking the sympathetic activation muscle blocker or other agent that would have the same effect of inhibiting the abnormal muscle activity.
    Type: Grant
    Filed: October 14, 1993
    Date of Patent: May 7, 1996
    Inventor: David R. Hubbard
  • Patent number: 5462862
    Abstract: Clustered antibiotic biosynthetic genes are employed for improvement of production of the antibiotic in microorganisms and for the isolation of other genes involved in the biosynthesis of the antibiotic. The invention is exemplified with improved production of penicillin in Penicillium chrysogenum, with the isolation of another clustered biosynthetic gene(s) and with the expression of penicillin biosynthetic genes in Acremonium chrysogenum.
    Type: Grant
    Filed: January 25, 1993
    Date of Patent: October 31, 1995
    Assignee: Gist-brocades N.V.
    Inventors: Martinus A. M. Groenen, Annemarie E. Veenstra, Pieter Van Solingen, Bertus P. Koekman, Lucia H. M. Van Der Voort, Juan F. Martin, Santiago Gutierrez, Bruno Diez, Emilio Alvarez, Jose L. Barredo, Christina Esmahan
  • Patent number: 5457032
    Abstract: New mutant .beta.-lactam acylases are provided exhibiting altered substrate specificities. These .beta.-lactam acylases are obtained by expression of a gene encoding said .beta.-lactam acylase and having an amino acid sequence which differs at least in one amino acid from the wild-type .beta.-lactam acylase.
    Type: Grant
    Filed: May 9, 1991
    Date of Patent: October 10, 1995
    Assignee: Gist-brocades NV
    Inventors: Wilhelmus J. Quax, Onno Misset, Jan M. Van Der Laan, Herman B. M. Lenting
  • Patent number: 5453566
    Abstract: Regulation of expression of genes encoded for in plant cell genomes is achieved by integration of a gene under the transcriptional control of a promoter which is functional in the host and in which the transcribed strand of DNA is complementary to the strand of DNA that is transcribed from the endogenous gene(s) one wishes to regulate. The integrated gene, referred to as antisense, provides an RNA sequence capable of binding to naturally existing RNAs, exemplified by polygalacturonase, and inhibiting their expression, where the anti-sense sequence may bind to the coding, non-coding, or both, portions of the RNA. The antisense construction may be introduced into the plant cells in a variety of ways and be integrated into the plant genome for inducible or constitutive transcription of the antisense sequence. A wide variety of plant cell properties may be modified by employing this technique.
    Type: Grant
    Filed: August 27, 1991
    Date of Patent: September 26, 1995
    Assignee: Calgene, Inc.
    Inventors: Christine K. Shewmaker, Jean C. Kridl, William R. Hiatt, Vic Knauf
  • Patent number: 5441937
    Abstract: Novel neurotrophic factor compositions are provided, obtained from lung tissue. The factors are found to be active on parasympathetic ganglion neurons enhancing acetylcholine activity. The compositions find use in the treatment of a number of eye disorders.
    Type: Grant
    Filed: January 21, 1994
    Date of Patent: August 15, 1995
    Assignee: Houston Biotechnology Incorporated
    Inventors: Thomas L. Wallace, David E. Potter, Craig E. Crosson
  • Patent number: 5424184
    Abstract: The present invention provides a process for determining genotypes in highly polymorphic systems by polymerase chain reaction amplification of cDNA or genomic DNA and direct sequencing polymerase chain reaction products using oligonucleotide primers. More specifically, Class I HLA genotypes can be unambiguously determined in any subject in 16-24 hours by direct sequencing of HLA-A, HLA-B, and HLA-C transcripts enzymatically amplified and sequenced using a limited number of selected oligonucleotides.
    Type: Grant
    Filed: May 8, 1991
    Date of Patent: June 13, 1995
    Assignee: Regents of the University of Minnesota
    Inventors: Pedro Santamaria, Michael T. Boyce-Jacino, Jose Barbosa, Stephen S. Rich, Anthony J. Faras
  • Patent number: 5420034
    Abstract: Nucleic acid sequences and methods for their use are provided which provide for seed-specific transcription, in order to modulate or modify expression in seed, particularly embryo cells. Transcriptional initiation regions are identified and isolated from plant cells such as seed embryo and seed coat and used to prepare expression cassettes which may then be transformed into plant cells for seed-specific transcription. The method finds particular use in conjunction with modifying fatty acid production in seed tissue.
    Type: Grant
    Filed: August 8, 1991
    Date of Patent: May 30, 1995
    Assignee: Calgene, Inc.
    Inventors: Jean C. Kridl, Vic C. Knauf
  • Patent number: 5364782
    Abstract: Thermostable and acid stable .alpha.-amylases are provided as expression products of genetically engineered .alpha.-amylase genes isolated from microorganisms, preferably belonging to the class of Bacilli. Both chemical and enzymatic mutagenesis methods are e.g. the bisulphite method and enzymatic misincorporation on gapped heteroduplex DNA. The mutant .alpha.-amylases have superior properties, e.g. improved thermostability over a broad pH range, for industrial application in starch processing and textile desizing.
    Type: Grant
    Filed: November 29, 1990
    Date of Patent: November 15, 1994
    Assignees: Gist-Brocades N.V., Plant Genetic Systems N.V.
    Inventors: Wilhelmus J. Quax, Yves Laroche, Adrianus W. H. Vollebregt, Patrick Stanssens, Marc Lauwereys
  • Patent number: 5364531
    Abstract: Immunoaffinity purifications are performed using non-aqueous media, desirably, a small amount of an aqueous buffered medium, and, optionally, a surfactant. Hydrophobic ligands can be extracted from samples, immunoaffinity purified and eluted to provide a substantially pure product.
    Type: Grant
    Filed: November 10, 1992
    Date of Patent: November 15, 1994
    Assignee: Hawaii Biotechnology Group, Inc.
    Inventors: Gary S. Bignami, Paul G. Grothaus
  • Patent number: 5340731
    Abstract: A fusion protein that can function as a removable label is prepared containing a polypetide such as an enzyme and an amino acid sequence having a substrate binding region of a polysaccharidase such as cellulase that has essentially no polysaccharidase activity. By contacting the fusion protein with a .beta.-1,4 glycan matrix such as cellulose, the substrate binding region binds to the matrix to immobilize the polypeptide. The polypetide or fusion protein can be removed from the matrix with a protease capable of cleaving a specific protease cleavage site, or with a solution having a low ionic strength or a high pH. The fusion protein can be prepared by recombinant DNA technology.
    Type: Grant
    Filed: April 8, 1992
    Date of Patent: August 23, 1994
    Assignee: University of British Columbia
    Inventors: Douglas G. Kilburn, Robert C. Miller, Neil Gilkes, R. Antony J. Warren
  • Patent number: 5336611
    Abstract: New proteolytic enzymes are provided exhibiting improved properties for application in detergents, especially laundry detergents. These enzymes are obtained by expression of a gene encoding a proteolytic enzyme having an amino acid sequence which differs at least in one amino acid from the wild type enzyme. Preferred enzymes are certain mutants derived from the serine protease of Bacillus nov. spec. PB92.
    Type: Grant
    Filed: October 11, 1989
    Date of Patent: August 9, 1994
    Assignee: Gist-brocades N.V.
    Inventors: Christiaan A. G. van Eekelen, Leonardus J. S. M. Mulleners, Johannes C. Van Der Laan, Onno Misset, Roelck A. Cuperus, Johan H. A. Lensink
  • Patent number: 5328839
    Abstract: A new oxido reductase enzyme activity obtainable from P. chrysogenum, involved in the production of .beta.-lactams, the set of genes encoding said enzyme activity, and a method to enhance said production by using the above-mentioned oxido reductase system and other oxido reductase systems or genes encoding for the same have been disclosed.
    Type: Grant
    Filed: March 24, 1992
    Date of Patent: July 12, 1994
    Assignee: Gist-Brocades
    Inventors: Yair Aharonowitz, Lucia H. M. van der Voort, Gerald Cohen, Roelof A. L. Bovenberg, Rachel Schreiber, Anat Argaman, Yossef Av-Gay, Helena M. Nan, Alfred Kattevilder, Harriet Palissa, Henk van Liempt
  • Patent number: 5324653
    Abstract: New proteolytic enzymes are provided exhibiting improved properties for application in detergents, especially laundry detergents. These enzymes are obtained by expression of a gene encoding a proteolytic enzyme having an amino acid sequence which differs at least in one amino acid from the wild type enzyme. Preferred enzymes are certain mutants derived from the serine protease of Bacillus nov. spec. PB92.
    Type: Grant
    Filed: April 24, 1991
    Date of Patent: June 28, 1994
    Assignee: Gist-Brocades N.V.
    Inventors: Christiaan A. G. Van Eekelen, Leonardus J. S. M. Mulleners, Johannes C. Van Der Laan, Onno Misset, Roelck A. Cuperus, Johan H. A. Lensink